Hims & Hers Health Inc. has announced a new offer allowing eligible new customers to access a 6-month supply of Wegovy®, a prescription medication for obesity care, at a reduced price of $549 per month. This limited-time offer is part of the company's commitment to making obesity treatments more affordable and accessible to millions of Americans. The package includes access to Hims & Hers' holistic approach to weight loss, which incorporates technology-driven solutions and a variety of weight loss treatment options. CEO and co-founder Andrew Dudum emphasized the company's dedication to increasing access to essential health care services.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.